Globus Medical (GMED) Finished Goods (2018 - 2025)
Globus Medical filings provide 8 years of Finished Goods readings, the most recent being $555.7 million for Q3 2025.
- On a quarterly basis, Finished Goods changed 0.46% to $555.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $555.7 million, a 0.46% change, with the full-year FY2024 number at $491.5 million, down 30.53% from a year prior.
- Finished Goods hit $555.7 million in Q3 2025 for Globus Medical, roughly flat from $558.4 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $769.7 million in Q3 2023 to a low of $172.1 million in Q3 2021.
- Median Finished Goods over the past 5 years was $237.4 million (2023), compared with a mean of $390.0 million.
- Biggest five-year swings in Finished Goods: soared 273.12% in 2023 and later crashed 30.53% in 2024.
- Globus Medical's Finished Goods stood at $177.8 million in 2021, then rose by 23.72% to $220.0 million in 2022, then skyrocketed by 221.64% to $707.5 million in 2023, then crashed by 30.53% to $491.5 million in 2024, then rose by 13.08% to $555.7 million in 2025.
- The last three reported values for Finished Goods were $555.7 million (Q3 2025), $558.4 million (Q2 2025), and $497.0 million (Q1 2025) per Business Quant data.